title: [Patient with TDS and increased PSA (implications in prostate biopsy)].
abstract: Since 70 years ago testosterone is considered a risk factor for prostate cancer and its supplementation in men with testosterone deficit syndrome is considered a risk for the development of a prostatic neoplasia. We discuss the case of a man with hypogonadism and increased PSA, the indications for biopsy and risks involved in testosterone supplementation, as well as recommended follow up. Over this practical base, we expose the current evidence on prostatic safety in men with testosterone supplementation.
authors.affiliation: Servicio de Urologia. Hospital Clinico . Universidad de Barcelona.Barcelona.Spain.
authors.forename: Eduardo
authors.initials: E
authors.lastname: García-Cruz
mesh_terms: D001706:Biopsy; D018450:Disease Progression; D006801:Humans; D007006:Hypogonadism / Q000209:etiology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000032:analysis*; D013739:Testosterone / Q000009:adverse effects / Q000172:deficiency* / Q000627:therapeutic use*
chemical_list: D013739:Testosterone; D017430:Prostate-Specific Antigen